MADRIGAL PHARMACEUTICALS, INC.

Lobbying client · Pennsylvania · filed 2025 to 2026

Biopharmaceutical company

$320,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (70096), not by name.

Firms hired 1

BALLARD PARTNERS $320,000 4 filings

Reported by year 2 years

2026 $240,000 2 filings
2025 $80,000 2 filings

Issues lobbied 1

Pharmacy 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 5 total

Q2

BALLARD PARTNERS

2nd Quarter (Apr 1 - June 30) 2026 · $120,000 income · posted Jul 15, 2026

View → Q1

BALLARD PARTNERS

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $120,000 income · posted Apr 16, 2026

View → 4AY

BALLARD PARTNERS

4th Quarter (Oct 1 - Dec 31) 2025 · $80,000 income · posted Jan 14, 2026

View → Q4Y

BALLARD PARTNERS Amended

4th Quarter (Oct 1 - Dec 31) 2025 · $60,000 income · posted Jan 14, 2026

View → RR

BALLARD PARTNERS

4th Quarter (Oct 1 - Dec 31) 2025 · posted Dec 9, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.